Long-only investment, evaluating companies from an operational, buy-and-hold perspective.Quipus Capital does not focus on market-driven dynamics and future price action. Instead, our articles focus on operational aspects, understanding the long-term earnings power of companies, the competitive dynamics of the industries where they participate, and buying companies that we would like to hold independently of how the price moves in the future. Most QC calls will be holds, and that is by design. Only a very sm ...

SAN FRANCISCO, June 27, 2025 (GLOBE NEWSWIRE) -- Today, a federal judge in California granted preliminary approval of a $38 million cash settlement between Sheet Metal Workers National Pension Fund, the International Brotherhood of Teamsters Local No. 710 Pension Fund, and International Union of Operating Engineers Pension Fund of Eastern Pennsylvania and Delaware, and Bayer AG to resolve a certified securities class action against the pharmaceutical giant and certain executives. Originally filed in 2020, t ...

There seem to be several reasons why the stock is struggling on the NYSE. Some of them include the Fed's delay in cutting interest rates, weak financialMr. Mavroudis is a professional portfolio manager specializing in institutional and private portfolios. He focuses on risk management, which is accompanied by in-depth financial market analysis (fundamental, macro and technical) to control the risk undertaken by the portfolios. He invests in all financial instruments globally (stocks, bonds, fx, commodities) ...

Cineverse Corp. (NASDAQ:CNVS) Q4 2025 Earnings Conference Call Transcript June 27, 2025 9:00 AM ET Company Participants Christopher J. McGurk - Chairman & CEO Erick Opeka - President & Chief Strategy Officer Gary S. Loffredo - Chief Legal Officer, Secretary & Senior Advisor Mark Antonio Huidor - COO & CTO Mark Wayne Lindsey - Chief Financial Officer Conference Call Participants Brian David Kinstlinger - Alliance Global Partners, Research Division Daniel Louis Kurnos - The Benchmark Company, LLC, Research Di ...

NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Altimmune and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On June 26, 2025, Altimm ...

NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tesla, Inc. ("Tesla" or the "Company") (NASDAQ: TSLA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Tesla and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On June 22, 2025, Tesla debuted its ...

NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Hims & Hers and certain of i ...

NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. ("Edgewise" or the "Company") (NASDAQ: EWTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Edgewise and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]June 26, 2025 ...

NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc. ("Tempus" or the "Company")(NASDAQ: TEM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Tempus and certain of its officers and/or ...

QuantumScape TodayQSQuantumScape$6.53 -1.12 (-14.59%) 52-Week Range$3.40▼$9.52Price Target$5.19Add to WatchlistEV battery maker QuantumScape NYSE: QS just had one of its best days in a long time. On June 25, shares rocketed up around 30%, marking the stock’s biggest single-day gain since July 2024. The stock’s surge comes as the company announced the integration of its “Cobra Separator Process” into its battery production. QuantumScape is on a mission to build the EV battery technology of the future. So, w ...